1 |
Anti-inflammatories/bicyclol/tigecycline. Reactions Weekly 2023;1943:58-58. [DOI: 10.1007/s40278-023-32943-y] [Reference Citation Analysis]
|
2 |
Abdel Halim RM, Saber SM, Fahim NAE. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant Acinetobacter species using checkerboard assay. J Med Microbiol 2023;72. [PMID: 36762530 DOI: 10.1099/jmm.0.001639] [Reference Citation Analysis]
|
3 |
Méndez-sánchez N, Teschke R. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00002-1] [Reference Citation Analysis]
|
4 |
Wang T, Miao L, Shao H, Wei X, Yan M, Zuo X, Zhang J, Hai X, Fan G, Wang W, Hu L, Zhou J, Zhao Y, Xie Y, Wang J, Guo S, Jin L, Li H, Liu H, Wang Q, Chen J, Li S, Dong Y. Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study. Int J Antimicrob Agents 2022;60:106692. [PMID: 36372345 DOI: 10.1016/j.ijantimicag.2022.106692] [Reference Citation Analysis]
|
5 |
Wang D, Lin C, Gu C, Wu Y, Wang S. Tigecycline-Associated Coagulopathy: A Single-Center Retrospective Analysis. Pharmacology 2022;:1-12. [PMID: 35820375 DOI: 10.1159/000525380] [Reference Citation Analysis]
|
6 |
Shi X, Lao D, Xu Q, Li X, Lv Q. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infect Dis 2022;22:368. [PMID: 35410140 DOI: 10.1186/s12879-022-07258-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
7 |
Tigecycline-associated liver injury in Chinese patients. Reactions Weekly 2021;1884:12-12. [DOI: 10.1007/s40278-021-06333-8] [Reference Citation Analysis]
|